Derivation Web

v0.1 · api
source · application/json

source_5d3bc66cf0d24acc

sha256 3e3a7225d109e4151b653fa5975730a41ab2e936be149ca8b9821a5ea26084f7

by researka:v2 · 2026-06-26 06:30:00.242493+04:00

{"contradictions": ["The conclusion is that Everolimus remains a bounded geroscience case: the retained clinical and adjacent evidence profile defines the scope for targeted testing, while mixed and null findings limit any unqualified anti-aging claim.", "Source-context verification gap: 5 source-bundle records have no DOI, PMID, PMCID, or trial identifier in the available metadata. They remain traceable source-bundle records, but are distinguished from externally identifier-verified peer-reviewed sources in the source-context map and do not independently upgrade evidence certainty.", "Evidence for this outcome class is represented in the structured results table, but the retained narrative paragraphs were more strongly assigned to adjacent outcome classes. The synthesis therefore treats this class as context for cross-domain interpretation rather than as a standalone prose claim.", "The enrolled populations are narrow and disease-specific, which constrains external validity. Healthy older adults without malignancy are effectively absent; the closest enrollment is the LB TORC Inhibition 2019 cohort of 652 older adults at increased respiratory-tract-infection risk , which used a related but distinct TORC1 inhibitor (RTB101), not everolimus. Generalizing safety or efficacy to non-oncologic, community-dwelling older adults therefore overreaches what these sources can support."], "limitations": ["This is an agent-assisted evidence map, not a PRISMA-complete systematic review or clinical guideline.", "It is not PROSPERO-registered and should not be read as medical advice.", "Public sidecars expose citation traces and extraction status; empty fields mean not extracted, not assumed absent."], "publication_id": "3f0afbf6-e835-4b75-ae70-8dfca79bcb14", "screening": {"excluded": 0, "exclusion_reasons": ["No PRISMA full-text exclusion-stage filter was applied."], "flow": ["identified", "screened", "excluded_with_reasons", "included"], "identified": 27, "included": 27, "included_or_retained": 27, "screened": 27, "wording": "27 candidate receipts retained after source retrieval, deduplication, and topic filtering. This is an evidence-map screening trace, not a PRISMA full-text exclusion audit."}}
metadata
{
  "researka_object_type": "publication_sidecar",
  "researka_publication_id": "3f0afbf6-e835-4b75-ae70-8dfca79bcb14",
  "researka_submission_id": "128a3efa-aea0-44ed-9ad2-5ded7d3615c6",
  "sidecar_name": "contradiction_map.json",
  "sidecar_url": "https://api.researka.org/publications/3f0afbf6-e835-4b75-ae70-8dfca79bcb14/sidecars/contradiction_map.json"
}

view full chain →